Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | POLB | P06746 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.62 |
| ▸ | MEN1 | O00255 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 5/20 | 0.62 |
| ▸ | RAB9A | P51151 | 5/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.62 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.62 |
| ▸ | RELA | Q04206 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | CASP3 | P42574 | 1/20 | 0.62 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.62 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27177997 | 1.00 | MAPT (0.78) | MAPTPOLBALDH1A1LMNAKMT2A | |
| SCHEMBL12186262 | 1.00 | MAPT (0.78) | MAPTPOLBALDH1A1LMNAKMT2A | |
| SCHEMBL14938560 | 0.88 | MAPT (0.78) | MAPTPOLBALDH1A1LMNAKMT2A | |
| SCHEMBL5732784 | 0.86 | RAB9A (0.81) | MAPTPOLBALDH1A1LMNAKMT2A | |
| SCHEMBL1563351 | 0.86 | RAB9A (0.81) | MAPTPOLBALDH1A1LMNAKMT2A | |
| SCHEMBL1563352 | 0.86 | RAB9A (0.81) | MAPTPOLBALDH1A1LMNAKMT2A | |
| SCHEMBL6638738 | 0.85 | MAPT (0.68) | MAPTPOLBALDH1A1LMNAKMT2A | |
| SCHEMBL1562114 | 0.85 | MAPT (0.68) | MAPTPOLBALDH1A1LMNAKMT2A | |
| SCHEMBL1562115 | 0.85 | MAPT (0.68) | MAPTPOLBALDH1A1LMNAKMT2A | |
| Phenyl(Methyl)Semicarbazone SCHEMBL17119918 | 0.84 | ALDH1A1 (1.00) | MAPTPOLBALDH1A1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4580403-A2 | APYRASE INHIBITORS | Texas Crop Science, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| US-20240101510-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. | 2024-03-28 | — | — | US | claimed |
| WO-2024050040-A2 | APYRASE INHIBITORS | TEXAS CROP SCIENCE (US) | 2024-03-07 | — | — | WO | claimed |
| US-6166260-A | Tandem reduction and host-guest complexation | ZEELAND CHEMICALS, INC. (US) | 2000-12-26 | — | — | US | claimed |
| US-20240101510-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. | 2024-03-28 | — | — | US | disclosed |
| EP-0858446-B1 | PHENYLCARBAMATES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES AND FUNGICIDES | BASF AG (DE) | 2001-03-07 | — | — | EP | disclosed |
| US-6191284-B1 | A FERROCENEYLPHOSPHINE LIGAND AND COMPLEXES USEFUL FOR HOMOGENEOUS CATALYTIC ENANTIOSELECTIVE HYDROGENATION | DEGUSSA-HUELS AKTIENGESELLSCHAFT (DE) | 2001-02-20 | — | — | US | disclosed |
| US-6166260-A | Tandem reduction and host-guest complexation | ZEELAND CHEMICALS, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| EP-0858446-A1 | PHENYLCARBAMATES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES AND FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-08-19 | — | — | EP | disclosed |
| WO-1997016415-A1 | PHENYLCARBAMATES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES AND FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101510-A1 | APYRASE INHIBITORS | APEH, DPEP1, PON1 | MAPT 4135/4885POLB 3494/4885ALDH1A1 827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.